What is MBOT's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.07B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for MBOT?

P/E (TTM) is n/a and 52-week range is $1.05 to $3.29 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s MBOT figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for MBOT?

The company profile lists revenue (TTM) near $349K, net income (TTM) near $-938M, EPS (TTM) near $-0.26 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Microbot Medical Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Hingham, Massachusetts, US, 67.2M shares outstanding, ISIN US59503A2042 when available from company profile and filing metadata.

Microbot Medical Inc

$MBOT

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.07

+0.00%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 43 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.

Employees

Website

www.microbotmedical.com/

IPO

1992-03-25

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)